Anti-nNOS (neuronal) (phospho S1417) antibody (ab5583)

Publishing research using ab5583? Please let us know so that we can cite the reference in this datasheet.

ab5583 has been referenced in 6 publications.

  • Pereira VS  et al. Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: involvement of nitric oxide. Eur Neuropsychopharmacol 23:1769-78 (2013). PubMed: 23434291
  • Garzón J  et al. RGSZ2 Binds to the Neural Nitric Oxide Synthase PDZ Domain to Regulate Mu-Opioid Receptor-Mediated Potentiation of the N-Methyl-D-Aspartate Receptor-Calmodulin-Dependent Protein Kinase II Pathway. Antioxid Redox Signal 15:873-87 (2011). WB ; Mouse . PubMed: 21348811
  • Donato J  et al. Leptin Induces Phosphorylation of Neuronal Nitric Oxide Synthase in Defined Hypothalamic Neurons. Endocrinology : (2010). IHC-FoFr ; Mouse . PubMed: 20881244
  • Sánchez-Blázquez P  et al. Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5:e11278 (2010). WB ; Mouse . PubMed: 20585660
  • Chiang HT  et al. Neuronal nitric oxide synthase activation is involved in insulin-mediated cardiovascular effects in the nucleus tractus solitarii of rats. Neuroscience 159:727-34 (2009). WB, IHC-P ; Rat . PubMed: 19167463
  • Lapointe J  et al. Hormonal and spatial regulation of nitric oxide synthases (NOS) (neuronal NOS, inducible NOS, and endothelial NOS) in the oviducts. Endocrinology 147:5600-10 (2006). WB, IHC-P ; Cow . PubMed: 16935840

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"